Financials Science Arts, Inc.

Equities

4412

JP3310370006

IT Services & Consulting

Delayed Japan Exchange 01:43:07 2024-06-28 EDT 5-day change 1st Jan Change
560 JPY -1.58% Intraday chart for Science Arts, Inc. +4.48% +1.08%

Valuation

Fiscal Period: August 2022 2023
Capitalization 1 7,982 4,767
Enterprise Value (EV) 1 7,319 4,263
P/E ratio 459 x -58.8 x
Yield - -
Capitalization / Revenue 12.1 x 6.18 x
EV / Revenue 11.1 x 5.53 x
EV / EBITDA 522,821,400 x -92,663,617 x
EV / FCF 100,439,103 x -225,829,213 x
FCF Yield 0% -0%
Price to Book 7.08 x 9.38 x
Nbr of stocks (in thousands) 6,487 6,584
Reference price 2 1,230 724.0
Announcement Date 22-11-29 23-11-29
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: August 2019 2020 2021 2022 2023
Net sales 1 179 222 365 659 771
EBITDA - - - 14 -46
EBIT 1 -92 -93 -97 11 -67
Operating Margin -51.4% -41.89% -26.58% 1.67% -8.69%
Earnings before Tax (EBT) 1 -95 -92 -95 9 -73
Net income 1 -95 -92 -95 9 -81
Net margin -53.07% -41.44% -26.03% 1.37% -10.51%
EPS 2 -32.92 -31.45 -31.29 2.680 -12.32
Free Cash Flow - - - 72.88 -18.88
FCF margin - - - 11.06% -2.45%
FCF Conversion (EBITDA) - - - 520.54% -
FCF Conversion (Net income) - - - 809.72% -
Dividend per Share - - - - -
Announcement Date 21-10-19 21-10-19 21-10-19 22-11-29 23-11-29
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period:
Estimates

Balance Sheet Analysis

Fiscal Period: August 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 250 309 260 663 504
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - 72.9 -18.9
ROE (net income / shareholders' equity) - -37.1% -37.2% 2.24% -15%
ROA (Net income/ Total Assets) - -13.2% -15.6% 1.19% -4.94%
Assets 1 - 695.6 610.4 754.1 1,639
Book Value Per Share 2 75.50 95.00 76.60 174.0 77.20
Cash Flow per Share 2 139.0 128.0 85.40 202.0 76.60
Capex - - - 18 20
Capex / Sales - - - 2.73% 2.59%
Announcement Date 21-10-19 21-10-19 21-10-19 22-11-29 23-11-29
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 4412 Stock
  4. Financials Science Arts, Inc.